Stay updated on Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Sign up to get notified when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s build/release “Revision” indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance/software version bump rather than a change to the displayed trial record history content.
    Difference
    0.1%
    Check dated 2026-04-24T16:41:34.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The history now shows Results Submitted and Revision: v3.5.2, replacing No Results Posted and Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:29:12.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the history list.
    Difference
    0.1%
    Check dated 2026-03-19T19:22:42.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The new screenshot shows Revision: v3.4.3 in the history, replacing Revision: v3.4.2. This is a small metadata update documenting the latest version.
    Difference
    0.1%
    Check dated 2026-03-12T10:43:07.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The screenshots depict the same history page with only minor UI/organizational changes and a new version entry added. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-18T18:32:34.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The funding lapse notice and the Revision: v3.4.1 note were removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:23:31.000Z thumbnail image

Stay in the know with updates to Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.